The Washington Post on MSN12d
FDA approves a novel drug for schizophrenia, a potential ‘game changer’Patients with schizophrenia are “all treated with pretty much the same medicines that work the same way,” Samit Hirawat, ...
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...
The path to discovering a blockbuster drug is often unpredictable. A promising molecule might be overlooked for decades, only ...
Off the scrapheap of discarded drugs and on its way to becoming the most highly anticipated approval of 2024, Bristol Myers ...
In a revealing Genomic Press Interview, Professor Illana Gozes discusses her groundbreaking work on activity-dependent ...
After decades of stagnation in the schizophrenia field, Bristol Myers Squibb’s $14 billion deal for Karuna Therapeutics has ...
The first new kind of treatment for schizophrenia patients in decades is arriving. The U.S. Food and Drug Administration approved the drug on Thursday, greenlighting the first of a new class of ...
The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to ...
In three medium-to large-sized clinical trials, Karuna showed that treatment with Cobenfy significantly relieved ...
A new type of schizophrenia drug developed by Boston biotech Karuna Therapeutics won approval from the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback